- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 32 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 2 residues within 4Å:- Chain A: H.290, K.293
Ligand excluded by PLIPEDO.5: 2 residues within 4Å:- Chain A: E.254, R.257
Ligand excluded by PLIPEDO.6: 1 residues within 4Å:- Chain A: R.277
Ligand excluded by PLIPEDO.7: 3 residues within 4Å:- Chain A: T.187, K.198, G.199
Ligand excluded by PLIPEDO.8: 4 residues within 4Å:- Chain A: R.285, P.319, A.320, T.369
Ligand excluded by PLIPEDO.9: 5 residues within 4Å:- Chain A: D.24, S.25, F.26, R.48, Y.418
Ligand excluded by PLIPEDO.10: 3 residues within 4Å:- Chain A: F.75, H.328, H.374
Ligand excluded by PLIPEDO.11: 5 residues within 4Å:- Chain A: H.60, G.62, T.63, G.64, L.66
Ligand excluded by PLIPEDO.12: 2 residues within 4Å:- Chain A: S.45, R.47
Ligand excluded by PLIPEDO.22: 7 residues within 4Å:- Chain B: P.3, C.4, G.46, R.47, R.48, E.50
- Ligands: EDO.27
Ligand excluded by PLIPEDO.23: 2 residues within 4Å:- Chain B: Q.143, H.145
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain B: K.155
- Chain C: R.131, P.150
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain B: L.268, A.269, H.274, V.276, Y.304
Ligand excluded by PLIPEDO.26: 3 residues within 4Å:- Chain B: R.44, S.465, Y.487
Ligand excluded by PLIPEDO.27: 6 residues within 4Å:- Chain B: D.24, S.25, F.26, R.48, Y.418
- Ligands: EDO.22
Ligand excluded by PLIPEDO.28: 1 residues within 4Å:- Chain B: R.277
Ligand excluded by PLIPEDO.43: 2 residues within 4Å:- Chain C: H.290, K.293
Ligand excluded by PLIPEDO.44: 2 residues within 4Å:- Chain C: E.254, R.257
Ligand excluded by PLIPEDO.45: 1 residues within 4Å:- Chain C: R.277
Ligand excluded by PLIPEDO.46: 3 residues within 4Å:- Chain C: T.187, K.198, G.199
Ligand excluded by PLIPEDO.47: 4 residues within 4Å:- Chain C: R.285, P.319, A.320, T.369
Ligand excluded by PLIPEDO.48: 5 residues within 4Å:- Chain C: D.24, S.25, F.26, R.48, Y.418
Ligand excluded by PLIPEDO.49: 3 residues within 4Å:- Chain C: F.75, H.328, H.374
Ligand excluded by PLIPEDO.50: 5 residues within 4Å:- Chain C: H.60, G.62, T.63, G.64, L.66
Ligand excluded by PLIPEDO.51: 2 residues within 4Å:- Chain C: S.45, R.47
Ligand excluded by PLIPEDO.61: 7 residues within 4Å:- Chain D: P.3, C.4, G.46, R.47, R.48, E.50
- Ligands: EDO.66
Ligand excluded by PLIPEDO.62: 2 residues within 4Å:- Chain D: Q.143, H.145
Ligand excluded by PLIPEDO.63: 3 residues within 4Å:- Chain A: R.131, P.150
- Chain D: K.155
Ligand excluded by PLIPEDO.64: 5 residues within 4Å:- Chain D: L.268, A.269, H.274, V.276, Y.304
Ligand excluded by PLIPEDO.65: 3 residues within 4Å:- Chain D: R.44, S.465, Y.487
Ligand excluded by PLIPEDO.66: 6 residues within 4Å:- Chain D: D.24, S.25, F.26, R.48, Y.418
- Ligands: EDO.61
Ligand excluded by PLIPEDO.67: 1 residues within 4Å:- Chain D: R.277
Ligand excluded by PLIP- 32 x SO4: SULFATE ION(Non-functional Binders)
SO4.13: 6 residues within 4Å:- Chain A: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.14: 4 residues within 4Å:- Chain A: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.15: 2 residues within 4Å:- Chain A: R.44, S.45
Ligand excluded by PLIPSO4.16: 3 residues within 4Å:- Chain A: R.44, S.465, Y.487
Ligand excluded by PLIPSO4.17: 2 residues within 4Å:- Chain A: R.170, P.428
Ligand excluded by PLIPSO4.18: 2 residues within 4Å:- Chain A: A.1, R.2
Ligand excluded by PLIPSO4.29: 6 residues within 4Å:- Chain B: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.30: 4 residues within 4Å:- Chain B: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.31: 4 residues within 4Å:- Chain B: G.193, K.194, S.242, G.243
Ligand excluded by PLIPSO4.32: 2 residues within 4Å:- Chain B: R.44, S.45
Ligand excluded by PLIPSO4.33: 2 residues within 4Å:- Chain B: T.187, G.199
Ligand excluded by PLIPSO4.34: 2 residues within 4Å:- Chain B: R.170, P.428
Ligand excluded by PLIPSO4.35: 2 residues within 4Å:- Chain B: K.321, R.329
Ligand excluded by PLIPSO4.36: 2 residues within 4Å:- Chain B: S.45, R.47
Ligand excluded by PLIPSO4.37: 3 residues within 4Å:- Chain B: I.158, P.159, H.162
Ligand excluded by PLIPSO4.38: 2 residues within 4Å:- Chain B: H.290, K.293
Ligand excluded by PLIPSO4.52: 6 residues within 4Å:- Chain C: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.53: 4 residues within 4Å:- Chain C: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.54: 2 residues within 4Å:- Chain C: R.44, S.45
Ligand excluded by PLIPSO4.55: 3 residues within 4Å:- Chain C: R.44, S.465, Y.487
Ligand excluded by PLIPSO4.56: 2 residues within 4Å:- Chain C: R.170, P.428
Ligand excluded by PLIPSO4.57: 2 residues within 4Å:- Chain C: A.1, R.2
Ligand excluded by PLIPSO4.68: 6 residues within 4Å:- Chain D: Y.11, S.12, R.353, S.356, W.357, D.358
Ligand excluded by PLIPSO4.69: 4 residues within 4Å:- Chain D: K.79, W.228, R.277, H.306
Ligand excluded by PLIPSO4.70: 4 residues within 4Å:- Chain D: G.193, K.194, S.242, G.243
Ligand excluded by PLIPSO4.71: 2 residues within 4Å:- Chain D: R.44, S.45
Ligand excluded by PLIPSO4.72: 2 residues within 4Å:- Chain D: T.187, G.199
Ligand excluded by PLIPSO4.73: 2 residues within 4Å:- Chain D: R.170, P.428
Ligand excluded by PLIPSO4.74: 2 residues within 4Å:- Chain D: K.321, R.329
Ligand excluded by PLIPSO4.75: 2 residues within 4Å:- Chain D: S.45, R.47
Ligand excluded by PLIPSO4.76: 3 residues within 4Å:- Chain D: I.158, P.159, H.162
Ligand excluded by PLIPSO4.77: 2 residues within 4Å:- Chain D: H.290, K.293
Ligand excluded by PLIP- 4 x P8Y: (2S,3S,4S,5R)-2-{[(4-methylpentyl)sulfonyl]methyl}piperidine-3,4,5-triol(Non-covalent)
P8Y.19: 12 residues within 4Å:- Chain A: D.127, F.128, W.179, E.235, Y.244, F.246, Q.284, Y.313, E.340, W.381, N.396
- Chain B: W.348
8 PLIP interactions:7 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:Y.244, A:F.246, A:F.246, B:W.348
- Hydrogen bonds: A:D.127, A:E.235, A:Y.313, A:N.396
P8Y.39: 14 residues within 4Å:- Chain A: W.348
- Chain B: D.127, F.128, W.179, E.235, Y.244, P.245, F.246, Q.284, Y.313, E.340, W.381, N.396, V.398
8 PLIP interactions:7 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:Y.244, B:P.245, B:F.246, A:W.348
- Hydrogen bonds: B:D.127, B:E.235, B:N.396
- Water bridges: B:N.396
P8Y.58: 12 residues within 4Å:- Chain C: D.127, F.128, W.179, E.235, Y.244, F.246, Q.284, Y.313, E.340, W.381, N.396
- Chain D: W.348
8 PLIP interactions:1 interactions with chain D, 7 interactions with chain C- Hydrophobic interactions: D:W.348, C:Y.244, C:F.246, C:F.246
- Hydrogen bonds: C:D.127, C:E.235, C:Y.313, C:N.396
P8Y.78: 14 residues within 4Å:- Chain C: W.348
- Chain D: D.127, F.128, W.179, E.235, Y.244, P.245, F.246, Q.284, Y.313, E.340, W.381, N.396, V.398
8 PLIP interactions:7 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:Y.244, D:P.245, D:F.246, C:W.348
- Hydrogen bonds: D:D.127, D:E.235, D:N.396
- Water bridges: D:N.396
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.20: 1 residues within 4Å:- Chain B: N.59
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.59
NAG.21: 5 residues within 4Å:- Chain B: T.138, N.146
- Chain C: L.96, S.97, P.98
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:T.138
NAG.59: 1 residues within 4Å:- Chain D: N.59
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:N.59
NAG.60: 5 residues within 4Å:- Chain A: L.96, S.97, P.98
- Chain D: T.138, N.146
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Santana, A.G. et al., Pharmacological chaperones for GCase that switch conformation with pH enhance enzyme levels in Gaucher animal models. To Be Published
- Release Date
- 2020-08-19
- Peptides
- Glucosylceramidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
SMTL ID : 6q1p.3 (2 other biounits)
Glucocerebrosidase in complex with pharmacological chaperone norIMX8
Glucosylceramidase
Toggle Identical (AC) Toggle Identical (BD)Related Entries With Identical Sequence
1ogs.1 | 1ogs.2 | 1y7v.1 | 1y7v.2 | 1y7v.3 | 1y7v.4 | 1y7v.5 | 1y7v.6 | 2f61.1 | 2f61.2 | 2j25.1 | 2j25.2 | 2nsx.1 | 2nsx.2 | 2nsx.3 | 2nsx.4 | 2nsx.5 | 2nsx.6 | 2nsx.7 | 2nsx.8 | 2nsx.9 | 2nt0.1 | 2nt0.2 | 2nt0.3 | 2nt0.4 | 2nt1.1 | 2nt1.2 | 2nt1.3 | 2nt1.4 | 2nt1.5 more...less...3gxd.1 | 3gxf.1 | 3gxf.2 | 3gxi.1 | 3gxi.2 | 3gxi.3 | 3gxi.4 | 3gxm.1 | 3gxm.2 | 3gxm.3 | 3gxm.4 | 3rik.1 | 3rik.2 | 3ril.1 | 3ril.2 | 6moz.1 | 6moz.2 | 6q1n.1 | 6q1n.2 | 6q1p.1 | 6q1p.2 | 6q6k.1 | 6q6l.1 | 6q6n.1 | 6tjj.1 | 6tjj.2 | 6ytp.1 | 6ytp.2 | 6yut.1 | 6yut.2 | 6yv3.1 | 6yv3.2 | 6z39.1 | 8p3e.1 | 8p41.1 | 8p41.2